The tweet was deleted by the author.
But we saved everything 🙂.
Molina Healthcare sent Father's Day greetings to dads and father figures. The company thanked them for their strength, care, and support.
Molina Healthcare stated that leading by example includes taking care of both physical and mental health. The company said a healthy dad helps build a healthy family.
MOH is trading at $195.37, sitting above the SMA-20 ($189.43), SMA-50 ($180.59), and SMA-200 ($168.00), which confirms a bullish bias across the short-, medium-, and long-term moving averages. The Ichimoku Kijun level on D1 is at $188.83, serving as immediate support since it is below the current price.
Momentum on D1 remains constructive with MACD at "Strong Buy" and ADX also positive, while RSI and CCI are both in "Buy" territory, reflecting mild upward bias without immediate overbought signals. However, Stoch RSI and BBP indicate the asset is approaching overbought territory, resulting in some divergence among oscillators. Weekly, MOH has fallen $4.91 (2.45%) from last week's close of $200.28, currently trading at the very bottom of the weekly range. This decline occurred amid notable weekly volatility of 5.95%, with price action showing a sharp retreat from the recent high and a clear shift in sentiment toward weakness.
Looking ahead, the projected trading range for the coming week is $189.60–$198.50, anchored well above the 52-week low of $121.06 but far from the 52-week high of $311.52. The probability of a price increase next week is moderate at 75%, supported by three out of four weekly trend indicators (RSI-W1, MACD-W1, MA-50-W1) signaling "Buy" or "Strong Buy," making a further decline less likely. The baseline scenario is for MOH to consolidate between $190 and $198.50. If bullish momentum resumes and price breaks above $198.50, a test of higher resistance levels is possible. Conversely, a drop below $189.60 may lead to further losses toward key support but with a very low probability (less than 20%) of a steep decline under current conditions.
Earlier, analysts noted that Molina Healthcare was exhibiting bullish momentum while consolidating within a defined trading range. The current analysis builds on this by identifying whether new signals point toward a potential trend change, with investors advised to monitor any emerging breakouts for actionable opportunities.